Johnson & Johnson

$143.10

+2.13 (+0.02%) Today
1 Day1D

5 Days5D

1 Month1M

6 Months6M

YTDYTD

1 Year1Y

2 Years2Y

5 Years5Y

MaxMax

About

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

CEO

Alex Gorsky

Employees

132200

Headquarters

One Johnson & Johnson Plaza New Brunswick, NJ, 08933

Founded

1886

Market Cap

Johnson & Johnson News

The rush to develop a COVID-19 vaccine: Is there reason to worry? Jun 10, 2020

Some alarm appears to be growing amid the rush to develop COVID-19 vaccines, with two prominent critics warning that politics could harm the process. In a New. York Times op-ed this week, Dr. Ezekiel J. Emanuel and Dr. Paul A. Offit of the University of Pennsylvania worried that potential pressure to produce good news for…

J&J accelerates development of its COVID-19 vaccine candidate Jun 10, 2020

Johnson & Johnson (NYSE:JNJ) announced today that its Janssen Pharmaceutical subsidiary has moved up first-in-human clinical trials of its COVID-19 vaccine candidate to late July, versus the previously planned start in September. “Based on the strength of the preclinical data we have seen so far and interactions with the regulatory authorities, we have been able to…

J&J accelerates development of its COVID-19 vaccine candidate Jun 10, 2020

Johnson & Johnson (NYSE:JNJ) announced today that its Janssen Pharmaceutical subsidiary has moved up first-in-human clinical trials of its COVID-19 vaccine candidate to late July, versus the previously planned start in September. “Based on the strength of the preclinical data we have seen so far and interactions with the regulatory authorities, we have been able to […]

J&J pledges $10m to fight racism in America Jun 05, 2020

Johnson & Johnson (NYSE:JNJ) this week pledged $10 million this week to fight racism and injustice in the U.S. In a response to the deaths of George Floyd in Minneapolis, Breonna Taylor in Louisville, Ky., and Ahmaud Arbery near Brunswick, Ga., J&J CEO Alex Gorsky said the $10 million pledge will span the next three years. It will…

J&J pledges $10m to fight racism in America Jun 05, 2020

BD CEO also expresses “frustration, anger and dismay over the racial inequality and injustice.” Johnson & Johnson (NYSE:JNJ) this week pledged $10 million this week to fight racism and injustice in the U.S. In a response to the deaths of George Floyd in Minneapolis, Breonna Taylor in Louisville, Ky., and Ahmaud Arbery near Brunswick, Ga., J&J […]